Differential metabolite results, listing metabolites with significant changes across treatment groups, including fold changes, and <i>p</i>-values.

Differential metabolite results, listing metabolites with significant changes across treatment groups, including fold changes, and <i>p</i>-values.

<p>Differential metabolite results, listing metabolites with significant changes across treatment groups, including fold changes, and <i>p</i>-values.</p>

Збережено в:

Бібліографічні деталі
Автор:	Ji-Xin Zhao (22056386) (author)
Інші автори:	Wen-Bin Zheng (3328680) (author), Shi-Chen Xie (10678094) (author), He Ma (583317) (author), Xiao-Tong Chen (4217488) (author), Ying-Qian Gao (22683622) (author), Lu-Yao Tang (22683625) (author), Meng-Ting Yang (10714266) (author), Fu-Long Nan (22056395) (author), Jing Jiang (130103) (author), Hany M. Elsheikha (6910232) (author), Xiao-Xuan Zhang (610969) (author)
Опубліковано:	2025
Предмети:	Biochemistry Microbiology Cell Biology Genetics Physiology Ecology Immunology Computational Biology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified showed negative associations quality reads produced oxidative stress response conducted metagenomic sequencing compositional changes coincided bile acid transformation aromatic compound processing 7 million genes rothia nasimurium </ lactobacillus intestinalis </ de novo </ untargeted serum metabolomics specific metabolic disruptions amino acid metabolism toxoplasma gondii </ limosilactobacillus reuteri </ lactobacillus johnsonii </ akkermansia muciniphila </ host systemic metabolism disrupts intestinal microbiota reuteri </ muciniphila </ johnsonii </ gondii </ host metabolism untargeted lc metabolic targets energy metabolism infection disrupts significant shifts reduced abundance rat model positively correlated pathways related novel microbial microbial diversity metabolites implicated marked reduction marked depletion key role immune modulation gut microbiota findings demonstrate enhanced glycan disease mechanisms comprehensive non community structure chronic stages active enzymes 18 sprague
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

KEGG pathway enrichment analysis of differential serum metabolites.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Spearman correlation analysis between gut microbial taxa and circulating metabolites, detailing correlation coefficients, significance values, and taxon–metabolite pairings indicative of microbiome–host metabolic interactions.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Correlation network between intestinal bacterial species and differential serum metabolites.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Pathway enrichment analysis of differential metabolites, highlighting significantly impacted metabolic pathways and associated enrichment statistics based on KEGG or other pathway databases.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Effects of <i>T. gondii</i> infection on rat gut microbiota diversity.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Untargeted serum metabolomics analysis before and after <i>T. gondii</i> infection.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Functional analysis of the intestinal microbial community following <i>T. gondii</i> infection.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Composition of intestinal microbial communities in the large intestine of rats before and after <i>T. gondii</i> infection.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Composition of intestinal microbial communities in the small intestine of rats before and after <i>T. gondii</i> infection.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Orthogonal partial least squares-discriminant analysis (OPLS-DA) of serum metabolomics data.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Quality control assessment of serum metabolomics data.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Heatmap of enriched KEGG pathways across samples, illustrating variations in pathway abundance.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Graphical abstract.
за авторством: Ji-Xin Zhao (22056386)
Опубліковано: (2025)

Image 3_Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.png
за авторством: Domenico Sergi (435399)
Опубліковано: (2025)

Image 1_Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.jpeg
за авторством: Domenico Sergi (435399)
Опубліковано: (2025)

Image 2_Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.jpeg
за авторством: Domenico Sergi (435399)
Опубліковано: (2025)

Image 1_Oral health indices and microbiota populations of adult cats consuming wet or dry diets.tiff
за авторством: Patrícia M. Oba (13186074)
Опубліковано: (2025)

Protocatechuic Acid alleviates D-gal-induced renal senescence and injury in mice by regulating taurine metabolism
за авторством: Songhao Tian (22609826)
Опубліковано: (2025)

Supplementary file 2_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.doc
за авторством: Zhen Yang (107412)
Опубліковано: (2025)

Supplementary file 1_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.pdf
за авторством: Zhen Yang (107412)
Опубліковано: (2025)

Supplementary file 4_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.docx
за авторством: Zhen Yang (107412)
Опубліковано: (2025)

Supplementary file 3_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.docx
за авторством: Zhen Yang (107412)
Опубліковано: (2025)

A. <i>T. gondii</i> gene group changes throughout the time course, expressed as log<sub>2</sub>(fold change) relative to pre-infection tachyzoites (t = 0). Grey area depicts the 95% confidence interval. n value refers to number of genes detected in each group. B. Gene set enrichment plot for most enriched terms from <i>T. gondii</i> transcriptome features at 15 min to 120 min. Five most significant terms are displayed for each database. C and D. Transcriptional profiles of top five upregulated and downregulated <i>T. gondii</i> transcription factors, respectively.
за авторством: Dominykas Murza (22676289)
Опубліковано: (2025)

Table 1_Association between vascular aging and cardiovascular-kidney-metabolic syndrome.docx
за авторством: Shuyi Zeng (8551422)
Опубліковано: (2025)

Table 1_GLP-1 agonists and exercise: the future of lifestyle prioritization.docx
за авторством: Roberto Codella (5856173)
Опубліковано: (2025)

羟丙基甲基纤维素通过对抗杆菌类驱动的CDCA富集，逆转结肠炎中菊糖的促炎作用
за авторством: 宇郑 (22678961)
Опубліковано: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
за авторством: Snehanshu Chowdhury (14957031)
Опубліковано: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
за авторством: Abhrajit Ganguly (21540245)
Опубліковано: (2025)

A. Library preparation strategy: poly-A(+) RNAs are captured by complementarity to reverse transcription primer, then second strand is synthesized using random hexamers and handles for sequencing are attached through two rounds of PCR. B. Mapped read distribution by species and by biotype. C and D. Principal component analysis of mouse and <i>T. gondii</i> transcriptomes, respectively. E and F. Volcano plots of Live <i>Toxoplasma</i>-infected mouse and <i>T. gondii</i> time points, respectively. To calculate Log<sub>2</sub>(Fold change), every timepoint is compared to corresponding samples (either macrophage or <i>Toxoplasma</i>) before infection (t = 0 min). Most significant and most upregulated transcripts are labelled. Number of significantly (p ≤ 0.05) downregulated and upregulated genes for each time point is given in blue and red, respectively. In F, 24-hour time point, red dots mark ROP
за авторством: Dominykas Murza (22676289)
Опубліковано: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
за авторством: Gia-Buu Tran (16437051)
Опубліковано: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
за авторством: Pochung Jordan Chou (14851578)
Опубліковано: (2025)

Supplementary Table 1 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
за авторством: David Olayinka Kamson (16617218)
Опубліковано: (2025)

Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
за авторством: David Olayinka Kamson (16617218)
Опубліковано: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
за авторством: William Kelly (15439117)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4o6tf5cnrct65c7qn2sornpg39